Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020
New Zealand (Aotearoa) experienced a Neisseria meningitidis serogroup B epidemic during 1991–2006, and incidence remains twice that of other high-income countries. We reviewed clinical, laboratory, and immunization data for children <15 years of age with laboratory-confirmed invasive meningococc...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2023-04-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/29/4/22-1397_article |
| _version_ | 1797861866362372096 |
|---|---|
| author | Cameron Burton Emma Best Matthew Broom Helen Heffernan Simon Briggs Rachel Webb |
| author_facet | Cameron Burton Emma Best Matthew Broom Helen Heffernan Simon Briggs Rachel Webb |
| author_sort | Cameron Burton |
| collection | DOAJ |
| description |
New Zealand (Aotearoa) experienced a Neisseria meningitidis serogroup B epidemic during 1991–2006, and incidence remains twice that of other high-income countries. We reviewed clinical, laboratory, and immunization data for children <15 years of age with laboratory-confirmed invasive meningococcal disease in Auckland, New Zealand, during January 1, 2004–December 31, 2020. Of 319 cases in 318 children, 4.1% died, and 23.6% with follow-up data experienced sequelae. Children of Māori and Pacific ethnicity and those living in the most deprived areas were overrepresented. Eighty-one percent were positive for N. meningitidis serogroup B, 8.6% for serogroup W, 6.3% for serogroup C, and 3.7% for serogroup Y. Seventy-nine percent had bacteremia, and 63.9% had meningitis. In New Zealand, Māori and Pacific children are disproportionately affected by this preventable disease. N. meningitidis serogroup B vaccine should be included in the New Zealand National Immunization Schedule to address this persistent health inequity.
|
| first_indexed | 2024-04-09T22:10:13Z |
| format | Article |
| id | doaj.art-0a467fc5e7614ef2bb0025b903c184fe |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-04-09T22:10:13Z |
| publishDate | 2023-04-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-0a467fc5e7614ef2bb0025b903c184fe2023-03-23T11:47:49ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592023-04-0129468669510.3201/eid2904.221397Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020Cameron BurtonEmma BestMatthew BroomHelen HeffernanSimon BriggsRachel Webb New Zealand (Aotearoa) experienced a Neisseria meningitidis serogroup B epidemic during 1991–2006, and incidence remains twice that of other high-income countries. We reviewed clinical, laboratory, and immunization data for children <15 years of age with laboratory-confirmed invasive meningococcal disease in Auckland, New Zealand, during January 1, 2004–December 31, 2020. Of 319 cases in 318 children, 4.1% died, and 23.6% with follow-up data experienced sequelae. Children of Māori and Pacific ethnicity and those living in the most deprived areas were overrepresented. Eighty-one percent were positive for N. meningitidis serogroup B, 8.6% for serogroup W, 6.3% for serogroup C, and 3.7% for serogroup Y. Seventy-nine percent had bacteremia, and 63.9% had meningitis. In New Zealand, Māori and Pacific children are disproportionately affected by this preventable disease. N. meningitidis serogroup B vaccine should be included in the New Zealand National Immunization Schedule to address this persistent health inequity. https://wwwnc.cdc.gov/eid/article/29/4/22-1397_articleMeningococcal diseasepediatricNew ZealandNeisseria meningitidissepsisbacteremia |
| spellingShingle | Cameron Burton Emma Best Matthew Broom Helen Heffernan Simon Briggs Rachel Webb Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020 Emerging Infectious Diseases Meningococcal disease pediatric New Zealand Neisseria meningitidis sepsis bacteremia |
| title | Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020 |
| title_full | Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020 |
| title_fullStr | Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020 |
| title_full_unstemmed | Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020 |
| title_short | Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020 |
| title_sort | pediatric invasive meningococcal disease auckland new zealand aotearoa 2004 2020 |
| topic | Meningococcal disease pediatric New Zealand Neisseria meningitidis sepsis bacteremia |
| url | https://wwwnc.cdc.gov/eid/article/29/4/22-1397_article |
| work_keys_str_mv | AT cameronburton pediatricinvasivemeningococcaldiseaseaucklandnewzealandaotearoa20042020 AT emmabest pediatricinvasivemeningococcaldiseaseaucklandnewzealandaotearoa20042020 AT matthewbroom pediatricinvasivemeningococcaldiseaseaucklandnewzealandaotearoa20042020 AT helenheffernan pediatricinvasivemeningococcaldiseaseaucklandnewzealandaotearoa20042020 AT simonbriggs pediatricinvasivemeningococcaldiseaseaucklandnewzealandaotearoa20042020 AT rachelwebb pediatricinvasivemeningococcaldiseaseaucklandnewzealandaotearoa20042020 |